Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes

about

Plasma copeptin, kidney disease, and risk for cardiovascular morbidity and mortality in two cohorts of type 2 diabetes

Item

http://www.wikidata.org/entity/Q58803910

description

im August 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 02 August 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в серпні 2018

@uk

name

Plasma copeptin, kidney diseas ...... two cohorts of type 2 diabetes

@en

Plasma copeptin, kidney diseas ...... two cohorts of type 2 diabetes

@nl

type

Item

label

Plasma copeptin, kidney diseas ...... two cohorts of type 2 diabetes

@en

Plasma copeptin, kidney diseas ...... two cohorts of type 2 diabetes

@nl

prefLabel

Plasma copeptin, kidney diseas ...... two cohorts of type 2 diabetes

@en

Plasma copeptin, kidney diseas ...... two cohorts of type 2 diabetes

@nl

P1476

Plasma copeptin, kidney diseas ...... two cohorts of type 2 diabetes

@en

P2093

Kamel Mohammedi

http://www.w3.org/2001/XMLSchema#string

Louis Potier

http://www.w3.org/2001/XMLSchema#string

Mathilde Fraty

http://www.w3.org/2001/XMLSchema#string

Michel Marre

http://www.w3.org/2001/XMLSchema#string

Pierre-Jean Saulnier

http://www.w3.org/2001/XMLSchema#string

Ray El Boustany

http://www.w3.org/2001/XMLSchema#string

Ronan Roussel

http://www.w3.org/2001/XMLSchema#string

Samy Hadjadj

http://www.w3.org/2001/XMLSchema#string

Stéphanie Ragot

http://www.w3.org/2001/XMLSchema#string

P2860

A review of the nonpressor and nonantidiuretic actions of the hormone vasopressin

Science review: Vasopressin and the cardiovascular system part 1--receptor physiology

A new equation to estimate glomerular filtration rate

Vasopressin V1a and V1b receptors: from molecules to physiological systems

The non-insulin-dependent diabetes, hypertension, microalbuminuria or proteinuria, cardiovascular events, and ramipril (DIABHYCAR) study: design, organization, and patient recruitment. DIABHYCAR Study Group

ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2012 of the European Society of Cardiology. Developed in collaboration with the

Tolvaptan in Patients with Autosomal Dominant Polycystic Kidney Disease

Diabetes mellitus, fasting glucose, and risk of cause-specific death.

Copeptin in the differential diagnosis of hyponatremia.

Copeptin levels associate with cardiovascular events in patients with ESRD and type 2 diabetes mellitus.

P2888

s12933-018-0753-5

P304

110

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12933-018-0753-5

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Frédéric Fumeron

Gilberto Velho

P577

2018-08-02T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1105978128

http://www.w3.org/2001/XMLSchema#string

P698

30071874

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

6071392

http://www.w3.org/2001/XMLSchema#string